These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 9869587)
1. Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum. Gangneux JP; Dullin M; Sulahian A; Garin YJ; Derouin F Antimicrob Agents Chemother; 1999 Jan; 43(1):172-4. PubMed ID: 9869587 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of aminosidine administered alone or in combination with meglumine antimoniate for the treatment of experimental visceral leishmaniasis caused by Leishmania infantum. Gangneux JP; Sulahian A; Garin YJ; Derouin F J Antimicrob Chemother; 1997 Aug; 40(2):287-9. PubMed ID: 9301998 [TBL] [Abstract][Full Text] [Related]
3. Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis. Ferreira FM; Castro RA; Batista MA; Rossi FM; Silveira-Lemos D; Frézard F; Moura SA; Rezende SA Parasitol Res; 2014 Feb; 113(2):533-43. PubMed ID: 24292604 [TBL] [Abstract][Full Text] [Related]
4. Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice. Reis LES; Fortes de Brito RC; Cardoso JMO; Mathias FAS; Aguiar Soares RDO; Carneiro CM; de Abreu Vieira PM; Ramos GS; Frézard FJG; Roatt BM; Reis AB Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827416 [TBL] [Abstract][Full Text] [Related]
5. Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice. Silva SC; Silva DF; Almeida TC; Perasoli FB; da Silva ATP; da Silva GN; Rezende SA Parasitol Res; 2018 Sep; 117(9):2881-2893. PubMed ID: 29943317 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum. Buffet PA; Garin YJ; Sulahian A; Nassar N; Derouin F Ann Trop Med Parasitol; 1996 Jun; 90(3):295-302. PubMed ID: 8758143 [TBL] [Abstract][Full Text] [Related]
7. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome. Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Faraut-Gambarelli F; Piarroux R; Deniau M; Giusiano B; Marty P; Michel G; Faugère B; Dumon H Antimicrob Agents Chemother; 1997 Apr; 41(4):827-30. PubMed ID: 9087498 [TBL] [Abstract][Full Text] [Related]
9. Oral leishmaniasis in an HIV-positive patient caused by two different zymodemes of Leishmania infantum. Cortés P; Cardeñosa N; Romaní J; Gállego M; Muñoz C; Barrio JL; Riera C; Portús M Trans R Soc Trop Med Hyg; 1997; 91(4):438-9. PubMed ID: 9373646 [No Abstract] [Full Text] [Related]
10. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Gramiccia M; Gradoni L; Orsini S Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of terbinafine treatment in Leishmania chagasi-infected hamsters (Mesocricetus auratus). Simões-Mattos L; Teixeira MJ; Costa DC; Prata JR; Bevilaqua CM; Sidrim JJ; Rocha MF Vet Parasitol; 2002 Jan; 103(3):207-16. PubMed ID: 11750114 [TBL] [Abstract][Full Text] [Related]
12. Quantification of Leishmania infantum kinetoplast DNA for monitoring the response to meglumine antimoniate therapy in visceral leishmaniasis. Pourabbas B; Ghadimi Moghadam A; Pouladfar G; Rezaee Z; Alborzi A Am J Trop Med Hyg; 2013 May; 88(5):868-71. PubMed ID: 23400573 [TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid. Kato KC; Morais-Teixeira E; Reis PG; Silva-Barcellos NM; Salaün P; Campos PP; Dias Corrêa-Junior J; Rabello A; Demicheli C; Frézard F Antimicrob Agents Chemother; 2014; 58(1):481-8. PubMed ID: 24189251 [TBL] [Abstract][Full Text] [Related]
14. Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis. Azevedo EG; Ribeiro RR; da Silva SM; Ferreira CS; de Souza LE; Ferreira AA; de Oliveira E Castro RA; Demicheli C; Rezende SA; Frézard F Expert Opin Drug Deliv; 2014 Oct; 11(10):1551-60. PubMed ID: 24962630 [TBL] [Abstract][Full Text] [Related]
15. Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum. Serna ME; Maldonado M; Torres S; Schinini A; Lima AP; Pandolfi E; de Arias AR Parasitol Int; 2015 Oct; 64(5):295-8. PubMed ID: 25843766 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis. Oliva G; Gradoni L; Cortese L; Orsini S; Ciaramella P; Scalone A; de Luna R; Persechino A Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912 [TBL] [Abstract][Full Text] [Related]
17. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis. Amusategui I; Sainz A; Tesouro MA Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510 [No Abstract] [Full Text] [Related]
18. Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum. Moreira VR; de Jesus LCL; Soares RP; Silva LDM; Pinto BAS; Melo MN; Paes AMA; Pereira SRF Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320726 [TBL] [Abstract][Full Text] [Related]
19. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate. Utili R; Rambaldi A; Tripodi MF; Andreana A Infection; 1995; 23(3):182-3. PubMed ID: 7499009 [TBL] [Abstract][Full Text] [Related]
20. Two cases of visceral leishmaniasis in Colombia resistant to meglumine antimonial treatment. Vélez ID; Colmenares LM; Muñoz CA Rev Inst Med Trop Sao Paulo; 2009; 51(4):231-6. PubMed ID: 19739006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]